Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

UPDATE 1-Philippines reports first cases of COVID-19 South African variant

Published 03/02/2021, 12:18 PM
Updated 03/02/2021, 12:20 PM
© Shutterstock
SVA
-

(Adds more details, background)
MANILA, March 2 (Reuters) - The Philippines has documented
six cases of the South African coronavirus variant, its health
ministry said on Tuesday, raising concern among its experts that
the current vaccines might be less effective.
The Philippines started its COVID-19 vaccination campaign on
Monday, an important milestone for a country among the hardest
hit by the pandemic in Asia, but the discovery of another
variant could complicate its recovery effort.
"While there is no evidence that this variant causes more
severe disease, the pattern of mutations within this variant
suggests higher transmissibility and may have an impact on
vaccine efficacy," the health ministry said in a statement.
Of the six cases with the South African variant, three were
detected locally and two were Filipinos returning from overseas.
The origin of the other case was still being verified.
The Philippines has so far found 87 cases with the more
transmissible variant.
President Rodrigo Duterte has said he would lift
restrictions on businesses and public transport in the capital
Manila once the government has secured 20 to 40 million doses of
coronavirus vaccines.
Although the Philippines has been in talks with most major
manufacturers of coronavirus vaccines to buy a combined 161
million doses, it has struggled to conclude deals, while stiff
competition has tightened supply.
Its first shipment of 600,000 doses of Sinovac SVA.O
vaccines on Sunday was a donation from China, part of which will
be used to inoculate military personnel.
It is expecting delivery of 1 million more doses of Sinovac
shots this month, which according to a Brazil institute is
effective against the British and South African variants.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.